Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,688 total articles

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Dyne Therapeutics announced upcoming presentation of new preclinical data demonstrating its FORCE platform's ability to cross the blood-brain barrier and effectively knockdown MAPT RNA in the central nervous system of nonhuman primates and mice. This breakthrough highlights the platform's potential applications beyond neuromuscular diseases into ne…

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Voyager Therapeutics announced eight presentations at ASGCT 2026 including a late-breaking oral presentation highlighting the safety and pharmacology of VY1706, its IV-delivered tau-silencing gene therapy targeting Alzheimer's disease. The company plans to submit an IND in Q2 2026 and initiate first-in-human dosing in the second half of 2026. Addit…

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Editas Medicine announced upcoming presentations of new preclinical data for EDIT-401, their lead in vivo CRISPR gene editing candidate, demonstrating its potential as a transformative treatment for hyperlipidemia and related cardiovascular diseases. These presentations will occur across multiple prestigious scientific conferences in May 2026, high…

Montauk Renewables Schedules First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 8:30 a.m. ET

Montauk Renewables Schedules First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 8:30 a.m. ET

Montauk Renewables, a NASDAQ-listed renewable energy company, announced its first quarter 2026 earnings conference call to be held on May 7, 2026. The company specializes in converting biogas into renewable natural gas and renewable electricity, operating multiple projects across several U.S. states. Financial results will be released prior to the …

Hillman Reports First Quarter 2026 Results

Hillman Reports First Quarter 2026 Results

Hillman Solutions Corp. reported a 3.0% increase in net sales to $370.1 million in Q1 2026 but recorded a net loss of $4.7 million. The company completed acquisitions of Campbell Chain & Fittings and Delaney Hardware, expanding its Industrial MRO and Pro Distribution presence. It raised its full-year 2026 net sales guidance while maintaining Adjust…

XCharge Files 2025 Annual Report on Form 20-F

XCharge Files 2025 Annual Report on Form 20-F

XCharge, a Nasdaq-listed company specializing in electric vehicle charging and energy storage solutions, announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2025. The report is accessible on the SEC and company websites, with hard copies available for shareholders upon request.

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Sana Biotechnology announced that its preclinical data on SG293, a novel in vivo CAR T cell therapy using proprietary fusogen technology, will be presented orally at the ASGCT 2026 Annual Meeting. SG293 targets CD8+ T cells to generate CD19-directed CAR T cells with precision, aiming to treat both B-cell cancers and autoimmune diseases while minimi…

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Cellectis announced new research on its TALE-based epigenetic editing approach showcased at the ASGCT annual meeting. This method achieves over 90% sustained gene knock-down in two key genes without creating DNA breaks or permanent sequence change, offering a potentially safer genome editing alternative. The platform expands Cellectis' gene editing…

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation, a Cayman Islands exempted blank check company listed on Nasdaq, announced that its Sponsor has deposited $850,000 into the trust account, granting an extension until July 25, 2026 to complete its initial business combination. This marks the utilization of the Company's option to extend the deadline by three mo…

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

TScan Therapeutics announced an upcoming poster presentation at the ASGCT 29th Annual Meeting featuring their novel CD45-targeted TCR-T cell therapies aimed at eliminating residual disease and preventing relapse post allogeneic hematopoietic cell transplantation in cancer patients. The data will be publicly available post-presentation, highlighting…

Millicom (Tigo) strengthens its position in Colombia following the successful acquisition of the government stake in Coltel

Millicom (Tigo) strengthens its position in Colombia following the successful acquisition of the government stake in Coltel

Millicom International Cellular S.A. (NASDAQ: TIGO) has acquired the remaining 32.5% government stake in Colombia Telecomunicaciones S.A. (Coltel), finalizing its consolidation of the company. This acquisition strengthens Millicom's market position in Colombia, providing increased scale and investment capacity to accelerate nationwide 5G rollout an…

Trupanion Publishes 2025 Annual Letter to Shareholders

Trupanion Publishes 2025 Annual Letter to Shareholders

Trupanion, Inc., a leading provider of medical insurance for cats and dogs, published its 2025 annual letter to shareholders emphasizing its strong market presence across North America and parts of Europe, its unique direct payment technology, and commitment to delivering value to pet owners. The letter reiterates the company's focus on pet medical…

Blue Moon Metals Confirms Final Investment Decision to Construct Nussir Project Mine, Intention to Construct the Springer Tungsten Mine and Concurrent C$150 Million Bought Deal Equity Offerings

Blue Moon Metals Confirms Final Investment Decision to Construct Nussir Project Mine, Intention to Construct the Springer Tungsten Mine and Concurrent C$150 Million Bought Deal Equity Offerings

Blue Moon Metals Inc. has approved the final investment decision to construct its Nussir copper-gold-silver project in Norway with production targeted to start by Q3 2027. The company is also initiating planning to restart the Springer tungsten mine in Nevada, aiming for production resumption by Q4 2027, capitalizing on rising tungsten prices. Conc…

Northeast Bank Reports Third Quarter Results and Declares Dividend

Northeast Bank Reports Third Quarter Results and Declares Dividend

Northeast Bank (NASDAQ: NBN) reported a robust third quarter with net income increasing to $29.9 million from $18.7 million year-over-year, driven by record loan origination volumes and strong net interest income. Total assets surpassed $5 billion, marking significant growth primarily from National Lending activities. The bank declared a quarterly …

Enovix to Report First Quarter 2026 Financial Results on May 13, 2026

Enovix to Report First Quarter 2026 Financial Results on May 13, 2026

Enovix Corporation, a Silicon Valley-based developer and manufacturer of advanced lithium-ion batteries, announced it will report its first quarter 2026 financial results on May 13, 2026, after market close. The company will host a live video call to discuss financial results, business updates, commercialization progress, and operational milestones…

Celestica Announces First Quarter 2026 Financial Results

Celestica Announces First Quarter 2026 Financial Results

Celestica Inc., a global tech solutions provider, announced Q1 2026 results with revenues up 53% year-over-year to $4.05 billion, adjusted EPS exceeding guidance at $2.16, and improved operating margins. The company raised its full-year 2026 revenue outlook to $19 billion from $17 billion and adjusted EPS to $10.15 from $8.75, citing stronger custo…